Search

Matthew P Kuruc

from Leonia, NJ
Age ~66

Matthew Kuruc Phones & Addresses

  • 340 Crescent Ave, Leonia, NJ 07605 (201) 585-7383
  • Monmouth Junction, NJ
  • Hackensack, NJ
  • Hoboken, NJ
  • 18 Hedgerow Dr, Englewood, NJ 07631 (201) 568-5778
  • Grandview, TX

Work

Company: Profact proteomics Position: President

Education

School / High School: Rutgers School of Engineering

Skills

Cancer • Proteomics • Lifesciences • Biotechnology • Biomarkers • Assay Development • Protein Chemistry • Biomarker Discovery • Hardware Diagnostics • Life Sciences • Drug Discovery • Pharmaceutical Industry • Biopharmaceuticals • Molecular Biology • Science • Cell Biology • Genomics • Immunology

Interests

New Ventures • Professional Networking • New Technology

Industries

Biotechnology

Resumes

Resumes

Matthew Kuruc Photo 1

Vice President Business Development

View page
Location:
New York, NY
Industry:
Biotechnology
Work:
ProFACT Proteomics
President
Education:
Rutgers School of Engineering
Skills:
Cancer
Proteomics
Lifesciences
Biotechnology
Biomarkers
Assay Development
Protein Chemistry
Biomarker Discovery
Hardware Diagnostics
Life Sciences
Drug Discovery
Pharmaceutical Industry
Biopharmaceuticals
Molecular Biology
Science
Cell Biology
Genomics
Immunology
Interests:
New Ventures
Professional Networking
New Technology

Business Records

Name / Title
Company / Classification
Phones & Addresses
Matthew Kuruc
President
Profact Proteomics
Whol Drugs/Sundries
1 Deerpark Dr, Monmouth Junction, NJ 08852
Matthew Kuruc
V P Of Business Development, Manufacturing Staff, Production
Ligochem Inc
Management Consulting Services Mfg Chemical Preparations
215 W 92 St, New York, NY 10025
(212) 575-0082

Publications

Us Patents

Compositions And Methods For Proteomic Investigations

View page
US Patent:
20040106131, Jun 3, 2004
Filed:
Aug 18, 2003
Appl. No.:
10/642776
Inventors:
Swapan Roy - East Brunswick NJ, US
John Krupey - Glen Rock NJ, US
Matthew Kuruc - Englewood NJ, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
A-00010

Monitoring Dysregulated Serum Complement, Coagulation, And Acute-Phase Inflammation Sub-Proteomes Associated With Cancer

View page
US Patent:
20180306798, Oct 25, 2018
Filed:
Apr 13, 2018
Appl. No.:
15/953260
Inventors:
- Monmouth Junction NJ, US
Devjit Roy - Casper WY, US
Matthew Kuruc - Leonia NJ, US
International Classification:
G01N 33/574
G01N 33/50
G01N 33/566
G06F 19/12
G06F 19/18
G06F 19/28
Abstract:
Embodiments include obtaining a stroma liquid biopsy from a patient and detecting a pattern of dysregulation amongst the biomarkers in the stroma liquid biopsy that can be monitored to help screen, diagnose or treat the patient for cancer. The biomarkers in the stroma liquid biopsy are involved in interconnected pathways such as the coagulation pathway, acute-phase inflammation pathway, and complement pathway. Particular embodiments involve assaying for levels of biomarkers, such as neutrophil elastase, as well as subpopulations of other biomarkers, such as subpopulations of SERPIN proteins. The levels of biomarkers and/or the ratios of levels of biomarker subpopulations can be informative for predicting the cancer disease state in the patient, thereby enabling more personalized or tailored medical intervention for the patient.
Matthew P Kuruc from Leonia, NJ, age ~66 Get Report